Gene · 6708
Papers1,813
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,813
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: Whole-exome sequencing for a hereditary elliptocytosis case with an unexpectedly low HbA1c. | Front Med (Lausanne) | 2023 | 38148910 | PubTator, text mining | PubMed |
| The Allosteric Regulation of Β-Ureidopropionase Depends on Fine-Tuned Stability of Active-Site Loops and Subunit Interfaces. | Biomolecules | 2023 | 38136634 | PubTator, text mining | PubMed |
| Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by HBBAS3 Gene Addition and Mutation-Specific RNA Interference. | Cells | 2023 | 38132168 | PubTator, text mining | PubMed |
| Case report: Genetic analysis of a novel intronic inversion variant in the SPTB gene associated with hereditary spherocytosis. | Front Genet | 2023 | 38111681 | PubTator, text mining | PubMed |
| Hereditary Spherocytosis: Can Next-Generation Sequencing of the Five Most Frequently Affected Genes Replace Time-Consuming Functional Investigations? | Int J Mol Sci | 2023 | 38069343 | PubTator, text mining | PubMed |
| SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma. | Int J Mol Sci | 2023 | 38069214 | PubTator, text mining | PubMed |
| Mutation Status and Glucose Availability Affect the Response to Mitochondria-Targeted Quercetin Derivative in Breast Cancer Cells. | Cancers (Basel) | 2023 | 38067318 | PubTator, text mining | PubMed |
| Two-dimensional CsPbI3/CsPbBr3 vertical heterostructure: a potential photovoltaic absorber. | Sci Rep | 2023 | 38057362 | PubTator, text mining | PubMed |
| An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma. | Heliyon | 2023 | 38053861 | PubTator, text mining | PubMed |
| ConDoR: tumor phylogeny inference with a copy-number constrained mutation loss model. | Genome Biol | 2023 | 38037115 | PubTator, text mining | PubMed |
| Fusing WGCNA and Machine Learning for Immune-Related Gene Prognostic Index in Lung Adenocarcinoma: Precision Prognosis, Tumor Microenvironment Profiling, and Biomarker Discovery. | J Inflamm Res | 2023 | 38026246 | PubTator, text mining | PubMed |
| Loss of chromosome 9p21 is associated with a poor prognosis in adenosquamous carcinoma of the pancreas. | Precis Clin Med | 2023 | 38024139 | PubTator, text mining | PubMed |
| Identification and validation of a prognostic-related mutant gene DNAH5 for hepatocellular carcinoma. | Front Immunol | 2023 | 38022557 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Unraveling activation-related rearrangements and intrinsic divergence from ligand-induced conformational changes of the dopamine D3 and D2 receptors. | bioRxiv | 2023 | 38014309 | PubTator, text mining | PubMed |
| Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype. | Nat Commun | 2023 | 37973922 | PubTator, text mining | PubMed |
| Identification of a carbohydrate recognition motif of purinergic receptors. | Elife | 2023 | 37955640 | PubTator, text mining | PubMed |
| The Evaluation of Prognostic Value and Immune Characteristics of Ferroptosis-Related Genes in Lung Squamous Cell Carcinoma. | Glob Med Genet | 2023 | 37915460 | PubTator, text mining | PubMed |
| Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma. | NPJ Precis Oncol | 2023 | 37907595 | PubTator, text mining | PubMed |
| Connexins in Cancer, the Possible Role of Connexin46 as a Cancer Stem Cell-Determining Protein. | Biomolecules | 2023 | 37892142 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/papers?page=6